Berman Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$205K Buy
2,731
+603
+28% +$47.9K 0.03% 259
2021
Q2
$172K Buy
2,128
+280
+15% +$22.9K 0.03% 263
2021
Q1
$144K Buy
1,848
+451
+32% +$35.4K 0.03% 233
2020
Q4
$119K Buy
1,397
+29
+2% +$2.4K 0.03% 225
2020
Q3
$105K Sell
1,368
-872
-39% -$66.5K 0.03% 223
2020
Q2
$162K Buy
2,240
+149
+7% +$10.6K 0.04% 165
2020
Q1
$137K Buy
2,091
+435
+26% +$30.7K 0.04% 155
2019
Q4
$113K Sell
1,656
-38
-2% -$2.59K 0.03% 210
2019
Q3
$123K Buy
1,694
+21
+1% +$1.52K 0.04% 186
2019
Q2
$119K Buy
1,673
+264
+19% +$18.7K 0.04% 187
2019
Q1
$95K Buy
1,409
+54
+4% +$3.49K 0.03% 199
2018
Q4
$79K Buy
+1,355
New +$84.8K 0.03% 203

Other funds holding CL

Berman Capital Advisors's CL Position: Q3 2021 in Review

Berman Capital Advisors increased its Colgate-Palmolive (CL) stake by 28% in Q3 2021, buying an estimated $47.9K and bringing the position to 2,731 shares worth $205K. The position accounts for 0.03% of the portfolio, ranked #259.

Berman Capital Advisors first reported a position in CL in Q4 2018 and has held it in 12 quarters since. 1,584 funds tracked by Wall St. Rank hold CL as of Q3 2021.

  • Berman Capital Advisors held 2,731 shares of Colgate-Palmolive worth $205K as of Q3 2021.
  • Berman Capital Advisors bought 603 Colgate-Palmolive shares in Q3 2021, an estimated $47.9K.
  • Colgate-Palmolive made up 0.03% of Berman Capital Advisors's portfolio in Q3 2021, its #259 holding.
  • Berman Capital Advisors first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 12 quarters since.
  • 1,584 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.